Patent AnalyticsExaminers
Rankings

Law firm or agent

Ionis Pharmaceuticals, Inc.

441 applicationsfiled 2006 to 2023

Allowance rate
85%
+9 pts vs the USPTO range 81% to 88%
Rejections before allowance
1.5
−0.1 vs the USPTO
Months to first action
12.9 mo
−5.7 vs the USPTO
Needed an RCE
30%
+3 pts vs the USPTO

Timeline

Applications by filing year: drag across the years to study a period

Allowed in green, abandoned in red, pending in grey. The figures above and the charts that can be recomputed by filing year follow the span you pick.

Compared with the office

Against every applicant before the USPTO

Unlock the comparison with the officeFree with an account. No card needed.

Create a free account

Trend

Allowance by filing year

Unlock the trendIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Domains

Where the applications fall

CPC subclasses

C12N Microorganisms or enzymes249 apps
A61K Medical preparations80 apps
C07H 77 apps
A61P Therapeutic activity of compounds13 apps
C12Q Measuring or testing processes involving enzymes or nucleic acids7 apps
C07D Heterocyclic compounds5 apps

Art units

1635183 apps
1674128 apps
162333 apps
163623 apps
167323 apps
163720 apps

Who they file for

Clients with the most applications

Bars show the share of decided applications that were allowed.

Unlock the clients they file forIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Rejection fingerprint

What gets rejected, by statute

Share of parsed office actions raising each ground; blue is the USPTO.

Unlock the rejection fingerprintIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

What works

Allowance by strategy used

Unlock what works for this filerIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Interviews

Does an interview help?

Unlock the interview figuresFree with an account. No card needed.

Create a free account

Applications

Every application in the record

ApplicationTitleFiledStatusRejectionsRCEsTo 1st action
18691207COMPOUNDS AND METHODS FOR REDUCING DNM1L OR DRP1 EXPRESSION2024-03-12Abandoned00n/a
18523746Compounds and Methods for Reducing LRRK2 Expression2023-11-29Allowed008.8 mo
18493610COMPOSITIONS FOR MODULATING ATAXIN 2 EXPRESSION2023-10-24Allowed1015.4 mo
15898005Method and apparatus for adaptive signal processing2012-01-10Allowed1012.0 mo
15397469Composition and method for controlled release2015-02-11Abandoned4123.0 mo
15939047Distributed ledger transaction verification2018-03-12Allowed3020.0 mo
15346043Thermal management of battery assemblies2021-04-13Pending2117.0 mo
15218702Machine learning model for anomaly detection2012-05-14Allowed1014.0 mo
15273342Wireless power transfer coil arrangement2015-06-15Abandoned4125.0 mo
15578988Catalyst for selective hydrogenation2018-07-16Allowed3022.0 mo
Unlock all 441 applications, each with its full timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in